Live
BioPharma DiveAfter raising $800M, Parabilis seeks an IPO to pursue ‘undruggable’ targetsCellNociceptive innervation limits tertiary lymphoid structures to promote lung cancerCellGenome instability triggers intercellular DNA transfer between human cellsFierceBiotechWith $30M launch, Oorja Bio breathes new life into South Korean fibrosis candidateFierceBiotechLilly pens $202M deal for preclinical DNA delivery biotech Engage as M&A streak continuesBioPharma DiveBristol Myers deepens AI investment with Anthropic dealBioPharma DiveOorja, run by Acceleron veterans, launches to make new fibrosis drugsEndpoints NewsPfizer's next-gen pneumonia shot beats Prevnar 20; Relay targets $175MClinical OMICsAnti-Inflammatory Drug Could Help Some People with DepressionBioPharma DiveImmunovant’s potential autoimmune ‘blockbuster’; Wave’s RNA editing updateFierceBiotechBMS taps Anthropic’s Claude for enterprise-wide AI adoption to speed R&D, global workflowsFierceBiotechIncyte pays Genesis $80M to expand AI-fueled drug discovery pact

Archive

Latest Oldest
Total 11594
Page 533 / 645
Query --